Author

Chayma Boussayoud

Institutions: Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine

Observed institutions: Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine

OpenAlex ID: A5065617150

Phase Ib Study of Enzalutamide with or Without Sorafenib in Patients with Advanced Hepatocellular Carcinoma

2020 · James J. Harding, Robin K. Kelley, et al. · The Oncologist · 18

A multicenter pilot study of nivolumab (NIVO) with drug eluting bead transarterial chemoembolization (deb-TACE) in patients (pts) with liver limited hepatocellular carcinoma (HCC).

2018 · James J. Harding, Joseph Patrick Erinjeri, et al. · Journal of Clinical Oncology · 14

Phase 1B study of enzalutamide (ENZA) with or without sorafenib (SORA) in patients (pts) with advanced hepatocellular carcinoma (HCC).

2018 · James J. Harding, Robin Kate Kelley, et al. · Journal of Clinical Oncology

Works count: 3

Citation count: 32

H-index: 2

I10-index: 2